ALEXANDRIA, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL PSORIASIS FOUNDATION, founded in 1968, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $12.6M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $11.7M left a modest 7% surplus.
THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE.
RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND...
RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS TOWARDS OUTSIDE-THE-BOX IDEAS AND SUPPORTED YOUNG RESEARCHERS, ENSURING PROGRESS TOWARD NOVEL TREATMENTS. THROUGH PARTNERSHIPS SUCH AS THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES (AMP AIM), NPF HAS WORKED WITH INDUSTRY AND NONPROFIT STAKEHOLDERS TO IDENTIFY MOLECULAR PATHWAYS AND ACCELERATE TREATMENT DEVELOPMENT. BRIDGE GRANTS HAVE ENABLED NEAR-MISS NIH RESEARCH APPLICATIONS TO SECURE ADDITIONAL DATA AND EVENTUALLY OBTAIN FEDERAL FUNDING, MULTIPLYING DONOR INVESTMENT MANY TIMES OVER. OVER THE LIFETIME OF THIS GRANT OFFERING, EVERY BRIDGE GRANT RECIPIENT SUCCESSFULLY OBTAINED FURTHER FUNDING AFTER RESUBMISSION, TURNING $1.5 MILLION IN NPF GRANTS INTO $13.5 MILLION IN FEDERAL SUPPORT. NPF COLLABORATED WITH THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES AND COMMUNITY ORGANIZATIONS TO EXPAND ACCESS TO DERMATOLOGIC CARE IN UNDERSERVED WASHINGTON, D.C. NEIGHBORHOODS. QUALITATIVE RESEARCH, SUCH AS THE S.T.R.A.N.D. INITIATIVE, EDUCATED HAIR STYLISTS ON RECOGNIZING SCALP CONDITIONS, BROADENING COMMUNITY AWARENESS AND EARLY DETECTION. THE NPF HEALTH CARE PROVIDER DIRECTORY WAS ENHANCED IN 2025 BY REQUIRING PROVIDERS TO ATTEST TO DELIVERING GUIDELINE-BASED, HIGH-QUALITY CARE FOCUSED ON MINIMAL DISEASE ACTIVITY AND CONTINUOUS PROFESSIONAL GROWTH.
PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND...
PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND RHEUMATOLOGY FELLOWS MEETING OFFERED DERMATOLOGY RESIDENTS AND RHEUMATOLOGY FELLOWS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES. IN FY 2025, THE NPF CELEBRATED THE INDEXING OF THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES, ALLOWING MANY MORE RESEARCHERS, CLINICIANS, AND PATIENTS TO ACCESS VALUABLE INFORMATION IN EACH ARTICLE.
ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY...
ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY ACCUMULATOR PROTECTIONS ACROSS 40 STATES. NPF REGULARLY ADVOCATES ON CAPITOL HILL FOR BETTER CARE, ACCESS, AND FAIR PRICING. IN FY 2025, NPF PROACTIVELY EDUCATED ITS COMMUNITY ABOUT SIGNIFICANT MEDICARE CHANGES THROUGH ARTICLES, PODCASTS, AND WEBINARS, HELPING PATIENTS NAVIGATE NEW OUT-OF-POCKET MAXIMUMS AND PRESCRIPTION OPTIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $12,648,481 | $11,595,768 | +0.1% |
| Expenses | $11,737,962 | $12,586,852 | -0.1% |
| Net Income | $910,519 | $-991,084 | -1.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CAROL OSTROW | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| EYAL OFIR | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARY CARROLL | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRIAN JANSSEN | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ANDY BLAUVELT MD | MEDICAL BOARD CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RON GRAU | PAST CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KEN ANSIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KELLI AMERINE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DIANA SANDLER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE LINDSAY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LARRY GREEN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL GRAFF | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ELAINE HUSNI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VALERIE HARRISON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATHLEEN GALLANT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN SCOTT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NICOLE KUBIN FROM MAY 2025 | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LEON KIRCIK MD FROM MAY 2025 | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEITH GRAFF FROM MAY 2025 | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LEAH MCCORMICK HOWARD | PRESIDENT/CEO | 40.00 |
Officer
|
$399,224 | $43,603 | $442,827 |
| RONALD GOLDSMAN | CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$226,395 | $20,625 | $247,020 |
| JENNIFER FAGERSTROM | CHIEF REVENUE OFFICER | 40.00 |
Key Emp
|
$231,654 | $47,071 | $278,725 |
| GUY EAKIN | CHIEF SCIENTIFC & MEDICAL OFFICER | 40.00 |
Key Emp
|
$254,350 | $33,812 | $288,162 |
| JASON HARRIS | VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY | 40.00 |
Highest
|
$158,156 | $18,207 | $176,363 |
| BREANNA BAER | VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS | 40.00 |
Highest
|
$149,303 | $24,983 | $174,286 |
| JENNIFER O'CONNOR | VICE PRESIDENT OF ADVANCEMENT | 40.00 |
Highest
|
$160,412 | $22,921 | $183,333 |
| KATHERINE SOUTHWICK | VICE PRESIDENT OF MARKETING & COMMUNICATIONS | 40.00 |
Highest
|
$144,256 | $17,388 | $161,644 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $12,648,481 | $11,737,962 | $14,911,131 | $910,519 |
| 2024 | $11,595,768 | $12,586,852 | $14,679,906 | $-991,084 |
| 2023 | $11,591,439 | $13,763,392 | $13,817,026 | $-2,171,953 |
| 2023 | $11,591,439 | $13,763,392 | $13,817,026 | $-2,171,953 |
| 2022 | $13,390,353 | $12,538,110 | $13,977,875 | $852,243 |
| 2021 | $12,657,666 | $11,129,734 | $15,989,040 | $1,527,932 |
| 2020 | $14,236,650 | $13,904,678 | $14,435,005 | $331,972 |
| 2019 | $14,215,254 | $13,425,637 | $12,437,744 | $789,617 |
Compare NATIONAL PSORIASIS FOUNDATION with other nonprofits in Virginia and across the country.